Cardiac Sciences Defibrillator Recall: Units May Fail When Needed

About 12,200 automated external defibrillators (AEDs) manufactured by Cardiac Science Corporation are being recalled because they may fail to deliver life-saving shocks when needed.

The defibrillator recall was announced on February 3 by FDA after Cardiac Science determined that the AEDs were defectively manufactured. The recalled units may not function correctly during a resuscitation attempt, which could lead to serious injury or death, the company said. The recall is a Class 1 recall, the most serious medical device recall category.

There have been no failure incidents reported in connection to the defective AEDs. The defect was found by internal quality control at Cardiac Science Corporation.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

The AED recall affects Cardiac Science’s Powerheart 9300A, 9300E, 9390A and 9390E, as well as the CardioVive 92532, the CardioLife 9200G and 9231. The recall is a separate issue from a medical device correction alert issued by the company on November 13 dealing with some of its defibrillators.

The affected AEDs were manufactured between October 19, 2009 and January 15, 2010. Any customers who purchased an AEDs during that time can check Cardiac Science’s website to determine whether their unit is affected by the recall. The company is also informing customers by letter.

Replacement defibrillators will be available after February 15 and will be replaced at no charge.

The company recommends that any recalled defibrillators be immediately taken out of service.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A product liability lawsuit filed against Novo Nordisk accuses the drug maker of failing to provide adequate warnings of Ozempic side effects, like stomach paralysis.
Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries.